{
    "nct_id": "NCT05733949",
    "official_title": "A Pilot Study of Spatiotemporal SBRT for Poly-Metastatic Cancer",
    "inclusion_criteria": "* Documented informed consent of the participant and/or legally authorized representative\n\n  * Assent, when appropriate, will be obtained per institutional guidelines\n* Age: >= 18 years\n* Karnofsky performance status > 60\n* Poly-metastatic disease, > 5 lesions, and with at least one lesion > 2.0 cm, with limited treatment options, and ineligible for or in progression under the standard systemic therapy\n* Pre-screening assessment confirms that the intervention can be administered without exceeding dose constraint guidelines\n* Patients with brain metastases can be included but brain metastases must be treated prior to enrollment and follow up magnetic resonance imaging (MRI) 3 months after treatment shows stable findings\n* Spinal cord metastases are allowed as long as treatment with or without radiation is completed\n* Prior radiotherapy in general is allowed, as long as the composite plan meets dose constraints\n* Life expectancy >= 3 months in the opinion of the treating investigators\n* Off systemic therapy for at least one month prior and one month after study intervention\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Judgement by the investigator that the patient is unsuitable to participate in the study and the patient is unlikely to comply with study procedures, restrictions, and requirements\n* Those not eligible for SBRT after review by a radiation oncologist\n* Serous medical comorbidities precluding radiotherapy\n* Unable to undergo a CT scan\n* Pregnant and/or breastfeeding women are excluded from this study as these agents may have the potential for teratogenic or abortifacient effects. Female patients of childbearing potentially must have a negative urine or serum pregnancy test within 72 hours prior to receiving therapy\n* On active systemic therapy\n* Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)",
    "miscellaneous_criteria": ""
}